Federal authorities say a single nurse practitioner prescribed 260,000 pills containing controlled substances to patients in more than 20 states over a four-year period, operating largely out of hotel rooms and coordinating with clients over an encrypted messaging app.
The case ended without a criminal charge. Joan Rubinger, a pain specialist whose website advertises a client list heavy with professional athletes, agreed in March to pay $1.4 million to settle a Justice Department civil complaint. She did not admit wrongdoing and agreed never again to prescribe controlled substances. The Drug Enforcement Administration revoked her prescribing registration in July, citing what an administrative law judge described as egregious conduct.
Reporting published this week by The Associated Press drew on seizure affidavits and court records unsealed at the news organization's request, which fill in how the operation worked and how it was discovered.
What the Government's Civil Complaint Alleged
The underlying lawsuit was filed by the Justice Department in the Eastern District of California in January 2025. The complaint asked a court to bar Rubinger from prescribing controlled substances and to impose civil penalties over more than 900 prescriptions it described as illegitimate.
According to the government's filing, between November 2019 and June 2024, Rubinger traveled city to city offering services ranging from intravenous flushes to controlled substance prescriptions. Her practice consisted of herself, a personal assistant, and a billing manager. No licensed physician supervised her or was employed by the practice.
The complaint alleged she met customers in non-medical settings such as hotel rooms, without diagnostic tools, medical records or the infrastructure required to treat chronic pain. It alleged she sold prescriptions for cash during brief text exchanges, provided price lists that let customers select from a menu of drugs including oxycodone, Percocet, Xanax and Adderall, and issued prescriptions without examination or documentation.
The filing further alleged she wrote prescriptions in the names of customers' friends and family members, many of whom did not consent, to conceal the quantities involved.
The claims were resolved by a $1.4 million settlement in which no liability was determined. A spokesman for Rubinger said her case was a civil action rather than a criminal matter, and that no administrative or disciplinary actions had been taken by the nursing boards in California and New York, where she is licensed. Federal prosecutors declined to say why they did not pursue criminal charges.
The 260,000 Figure Needs a Careful Reading
Two different numbers are circulating, and they measure different things.
The 260,000 figure, drawn from federal court filings, refers to pills containing controlled substances prescribed over a four-year period to patients in more than 20 states. The civil complaint separately sought penalties for more than 900 individual prescriptions it characterized as illegitimate.
A single prescription can cover many pills, so both numbers can be accurate at once. Coverage describing 260,000 prescriptions is misreading the filings.
Agents also seized nearly $170,000 from a bank account under a warrant that deemed the money crime proceeds. Investigators say she collected hundreds of thousands of dollars through a digital money transfer app, requiring payment before a prescription was issued.
How the Case Surfaced, and What It Says About Oversight
The DEA opened its investigation in 2022 after a tip from the spouse of a former professional football player. She told authorities, and later told the AP, that she learned during an emergency room visit that she had been flagged for receiving excessive pain medication prescriptions. According to the DEA, more than 20 oxycodone prescriptions written for her husband over two years had been recorded in her name.
That detail is the part with the widest relevance. A prescription written in someone else's name does not just hide volume from regulators. It attaches a controlled substance history to a person who never received the drug, which can shape how clinicians treat them later.
The structural question the case raises is how prescribing at this alleged scale could continue across state lines for years. Prescription drug monitoring programs are run by states rather than by the federal government. Most states share data through interstate hubs, but participation and query requirements vary, and a prescriber moving between jurisdictions can look like a small presence in each one while representing a large volume in aggregate.
Supervision rules differ as well. Many states, including California, require nurse practitioners in most circumstances to work under a physician's supervision when prescribing opioids. In early 2024, the DEA inspected the office where Rubinger had registered her practice, which belonged to an orthopedic surgeon she had shadowed years earlier. The surgeon told authorities he had no role supervising her and no knowledge of her prescribing, according to the order revoking her registration.
Practical Checks for Patients and Families
Nothing in this case should prompt anyone to stop a prescribed medication. Abrupt discontinuation of opioids or benzodiazepines carries its own serious risks, including withdrawal and, for opioids, a drop in tolerance that raises overdose risk if use resumes.
Reasonable checks are simpler. A legitimate controlled substance prescriber conducts an examination, keeps medical records, and can be reached through a verifiable practice address. Payment by cash-only transfer app for a prescription written after a text exchange is not a normal clinical arrangement.
State medical and nursing boards publish license verification tools that show a prescriber's status and any disciplinary history. Patients can also ask a pharmacist whether a prescription pattern looks unusual, since pharmacists share a legal responsibility to evaluate whether a prescription is legitimate.
Anyone concerned about a prescriber can report it to the DEA at 1-877-792-2873, and state boards accept complaints directly from patients. Anyone concerned about their own or a family member's use of prescribed opioids or benzodiazepines should raise it with a clinician and can find treatment options through the SAMHSA National Helpline at 1-800-662-4357.
Key Questions Answered
What was alleged? Federal court filings allege a nurse practitioner prescribed 260,000 pills containing controlled substances to patients in more than 20 states over four years. A Justice Department civil complaint sought penalties over more than 900 prescriptions it called illegitimate.
How did the case end? She agreed in March to pay $1.4 million to settle the civil complaint without admitting wrongdoing, and agreed never again to prescribe controlled substances. The DEA revoked her prescribing registration in July.
Was anyone charged with a crime? No. The matter was handled as a civil action and an administrative revocation. Prosecutors declined to say why they did not bring criminal charges.
Is it 260,000 prescriptions or 260,000 pills? Pills. The prescription count in the civil complaint is more than 900. Descriptions of 260,000 prescriptions are inaccurate.
How could this continue across state lines? Prescription monitoring programs are state-run with varying data-sharing and query rules, and nurse practitioner supervision requirements differ by state, so a traveling prescriber can appear small in each jurisdiction.
Should patients stop taking prescribed opioids? No. Stopping opioids or benzodiazepines abruptly carries serious risks. Concerns should go to a clinician.
How can someone check a prescriber? State medical and nursing boards offer online license verification showing status and disciplinary history. Pharmacists can also flag unusual prescribing patterns.
